Dianne E. van der Wal: My Favourite Enzymes in Platelets. Very Interesting Tool!
Dianne E. van der Wal, Researcher at ANZAC Research Institute (Sydney Local Health District), quoted Chemical Biology’s post on LinkedIn:
“My favourite enzymes in platelets. Very interesting tool!”
Quoting Chemical Biology’s post:
“How can we see the enzymes that make pathogens so virulent? Read more about it in this Advance Article by Tom Wennekes et al., ‘Selective labeling and visualization of viral and bacterial neuraminidases using ortho-quinone methide-based probes’
This study introduces ortho-quinone methide-based probes that selectively label and visualize viral and bacterial neuraminidases. The probes allow imaging of active neuraminidases in complex biological samples, improving specificity and reducing nonspecific labeling.
Read the full article here:”
Title: Selective labeling and visualization of viral and bacterial neuraminidases using ortho-quinone methide-based probes
Authors: Erianna I. Alvarado-Melendez, Simon T. Ruessink, Karin Strijbis, Tom Wennekes
Discover the latest in Hemostasis Today.
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage
-
Feb 23, 2026, 11:29Emma Lefrancais: Uncovering A Key Role for The IL-33/ST2 Axis in Platelet Biology with Lucie Gelon
-
Feb 22, 2026, 14:16Ilenia Calcaterra: From Representation to Intellectual Independence in Women in Science
-
Feb 22, 2026, 13:27Pete Stibbs: New AHA and ACC PE Guidelines Finally Align with Real Clinical Practice
-
Feb 22, 2026, 10:39Tagreed Alkaltham: Fibrinogen Concentrate Is a Deliberate Clinical Choice in Acute Bleeding
-
Feb 22, 2026, 09:38Abdulrahman Nasiri: Significant Shifts In The 2026 AHA/ACC Guidelines for Acute Pulmonary Embolism
-
Feb 22, 2026, 09:22Shiny K. Kajal: Not All Transfusion Reactions Are Immunohematologic Incompatibilities